Hill Emily Luisa

Chief Financial Officer | Chief Financial Officer

2 companies

Good

Trades Analyzed

12M Win Rate

66.7%

Avg 3M Return

-7.4%

Avg 12M Return

+17.3%

Hill Emily Luisa is a Chief Financial Officer at REPL with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $3.6M based on current market prices.

Holdings by Company

REPLDec 19, 2025

Current Shares194.4K

Value$663.8K

Net Activity-20,627

Bought: 0Sold: 20.6K

PTCTMar 27, 2023

Current Shares38.9K

Value$2.93M

Net Activity-49,913

Bought: 0Sold: 49.9K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 25, 2022	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	211	$39.31	$8,295.25	-0.6%	+2.6%	+18.4%
Jan 7, 2022	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	800	$38.53	$30,820.00	-3.5%	+12.9%	+3.2%
Jan 4, 2022	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	173	$41.16	$7,121.03	-0.7%	+5.9%	-3.4%
Feb 1, 2021	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	541	$56.96	$30,813.20	-2.3%	-	-
Jan 25, 2021	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	275	$62.05	$17,064.85	-1.1%	-	-
Jan 8, 2021	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sale+OE	26,033	$69.75	$1,815,801.75	-21.2%	-	-
Jan 5, 2021	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	288	$62.37	$17,962.56	-1.1%	-	-
Jun 29, 2020	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	2,581	$52.50	$135,502.50	-15.9%	-	-
Jan 23, 2020	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	330	$53.25	$17,571.51	-4.6%	-	-
Jan 7, 2020	PTCT Ptc Therapeutics, Inc.	Chief Financial Officer	Sell	384	$48.41	$18,588.05	-1.7%	-	-